ClinicalTrials.gov
ClinicalTrials.gov Menu

RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03219255
Recruitment Status : Recruiting
First Posted : July 17, 2017
Last Update Posted : July 26, 2018
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 31, 2021
  Estimated Study Completion Date : March 31, 2021